Medications

As states consider taxing opioids, drugmakers push back

Facing a rising death toll from drug overdoses, state lawmakers across the country are testing a strategy to boost treatment for opioid addicts: Force drug manufacturers and their distributors to pay for it.

Neuroscience

Vagus nerve stimulation promising in Crohn's disease

(HealthDay)—Vagus nerve stimulation may represent a new therapeutic option for patients with Crohn's disease (CD), according to a report published online April 18 in the Journal of Internal Medicine.

Medical research

Improving medicine acceptance in kids: A matter of taste

Despite major advances in the pharmaceutical treatment of disease, many children reject medicines due to an aversion to bitter taste. As such, bitterness presents a key obstacle to the acceptance and effectiveness of beneficial ...

HIV & AIDS

Patents making new AIDS drugs expensive, MSF says

New potentially life-saving HIV drugs are "beyond reach" due to restrictive patents, Doctors Without Borders (MSF) said Tuesday, even though basic medication for the disease has become cheaper.

Diabetes

Report updates impact of hypoglycemia in diabetes

(HealthDay)—An update of the current state of knowledge about the impact of hypoglycemia on patients with diabetes reviews outcomes, strategies to prevent hypoglycemia, and current knowledge gaps, and has been published ...

Diabetes

Microaneurysm turnover IDs macular edema development

(HealthDay)—Microaneurysm (MA) turnover independently predicts the development of clinically significant macular edema (CSME) in patients with non-proliferative diabetic retinopathy (NPDR), according to a study published ...

Diseases, Conditions, Syndromes

Urodynamic studies affect diagnoses, but not treatment

(HealthDay)—Although preoperative urodynamic studies frequently change clinical diagnoses, they rarely lead to changes in the surgical or global treatment plans for women with stress urinary incontinence (UI), according ...

page 7 from 11